Metabolic Surgery for Tackling Type II Diabetes Epidemic

*Siba Senapati

Received: September 20, 2017;   Published: September 27, 2017

DOI: 10.26717/BJSTR.2017.01.000401

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Type II Diabetes is a serious chronic metabolic dysfunction leading to increased morbidity, mortality and cost. Globally an estimated 422 million adults were living with diabetes in 2014, compared to 108 million in 1980. The global prevalence of diabetes has nearly doubled since 1980, rising from 4.7% to 8.5% in the adult population. This reflects an increase in associated risk factors such as being overweight or obese. Over the past decade diabetes has risen faster in low and middle-income countries than in highincome countries.Diabetes caused 1.5 million deaths in 2012. Higher than optimal blood glucose caused an additional 2.2 million deaths, by increasing the risks of cardiovascular and other diseases. Diabetes is associated with significant complications which include heart attack, stroke, kidney failure, leg amputation, vision loss and nerve damage. Diabetes and its complications bring about substantial economic cost to people and health care system by its direct and indirect economic impact.

Introduction| Evolution of Metabolic Surgery| Clinical Evidence| Diabetes Remission| Contraindication| Follow-up|